Gilead Sciences to create 140 jobs at Irish operations
US pharmaceutical company Gilead Sciences is creating 140 jobs here as it plans to invest about €7m in its Irish operations.
Gilead said it is in the process of selecting a location for its new Dublin office, while the majority of the new positions will be based at Gilead’s existing Cork facilities.
The company said it expects to fill 80 of the positions over the coming 12 months, with the remainder hired by early 2022.
The new jobs will include clinical development, process development and analytical operations, legal, human resources, supply chain, information technology, facilities and engineering, and financial shared services positions.
Gilead’s sites in Ireland include a drug product manufacturing and packing facility in Carrigtwohill in Co Cork that manufactures and packages 22 of its drug products.
The company also has a financial shared services centre in Little Island in Co Cork and a distribution centre in Dublin that distributes to 90 markets worldwide.
Gilead’s manufacturing operations in Ireland supply countries across Europe and other parts of the world outside of the US.
The company has been in Ireland for the last 20 years and has invested more than €225m in its Irish operations. It has 370 full-time employees in Ireland and an additional 119 contingent workers.
“This is really positive news from the pharmaceutical industry in Ireland. We are delighted that, off the back of an already successful operation in the country, Gilead has decided to invest further in Ireland, creating 140 new roles,” IDA Ireland’s chief executive Martin Shanahan said.
“It demonstrates a huge vote of confidence in Ireland and our strong value proposition,” he added.
The pharma company is currently working on an experimental antiviral drug, remdesivir, which aims to help improve outcomes for patients with Covid-19.]
Reference: RTE.ie
